Report overview
Kidney cancer is?cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They're located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.
This report contains market size and forecasts of Kidney Cancer Therapeutics in Global, including the following market information:
Global Kidney Cancer Therapeutics Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Kidney Cancer Therapeutics market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Surgery Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Kidney Cancer Therapeutics include Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer and Exelixis and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Kidney Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Kidney Cancer Therapeutics Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Kidney Cancer Therapeutics Market Segment Percentages, by Type, 2022 (%)
Surgery
Immunotherapy
Targeted Therapy
Other
Global Kidney Cancer Therapeutics Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Kidney Cancer Therapeutics Market Segment Percentages, by Application, 2022 (%)
Renal Cell Carcinoma
Renal Pelvis Cancer
Other
Global Kidney Cancer Therapeutics Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Kidney Cancer Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Kidney Cancer Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Kidney Cancer Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novartis
Bristol-Myers Squibb
Pfizer
Roche
Amgen
Aveo Pharmaceuticals
Bayer
Exelixis
Eisai
